Regeneron Hopes Its High-Dose Aflibercept Will Ease Eylea Pressure

Execs Expect BCMA Bispecific To Stand Out In Competitive Space

 
• By Alaric DeArment
Regeneron announced its first quarter 2023 earnings on 4 May • Source: Shutterstock

More from Earnings

More from Business